Basics Amylyx Pharmaceuticals, Inc. IPO Date: January 7, 2022 Sector: Healthcare Industry: Biotech Market Cap: $1.63B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.42% Avg Daily Range (30 D): $0.44 | 3.13% Avg Daily Range (90 D): $0.30 | 3.08% Institutional Daily Volume Avg Daily Volume: 1.16M Avg Daily Volume (30 D): 1.7M Avg Daily Volume (90 D): 1.47M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 90 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 1,468 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $1.97M Avg Inst. Trade (90 D): $1.89M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.3M Avg Closing Trade (30 D): $2.81M Avg Closing Trade (90 D): $2.39M Avg Closing Volume: 154.17K     News Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight Jul 14, 2025 @ 10:26 PM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C. Jul 8, 2025 @ 1:00 AM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C. Oct 18, 2024 @ 11:26 AM Why Amylyx Pharmaceuticals Stock Was So Healthy Th... Source: Eric Volkman May 10, 2024 @ 6:01 PM Breaking Down Amylyx Pharma: 9 Analysts Share Thei... Source: Benzinga Insights Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.49 $-.46 $-.42 Diluted EPS $-2.49 $-.46 $-.42 Revenue $ -.25M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -187.6M $ -41.44M $ -35.91M Operating Income / Loss $ -196.98M $ -42.86M $ -37.8M Cost of Revenue $ M $ M $ M Net Cash Flow $ -16.18M $ -1.68M $ -17.62M PE Ratio